Here, we demonstrated that CCR5-expressing primary glioblastoma cells and glioblastoma stem cells (GSC) invasion, when enhanced by recombinant CCL5, was also significantly inhibited by adding maraviroc. The gene discussed is CCR5; the disease is glioblastoma.